Vanda Pharmaceuticals (VNDA) Enterprise Value Growth (5y) (2015 - 2026)
Vanda Pharmaceuticals (VNDA) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | Vanda Pharmaceuticals | 306.22 Mn | 103.91 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.76% |
| Dec 31, 2025 | 6.42% |
| Sep 30, 2025 | 3.36% |
| Jun 30, 2025 | 0.86% |
| Mar 31, 2025 | -1.77% |
| Dec 31, 2024 | -3.72% |
| Sep 30, 2024 | -9.61% |
| Jun 30, 2024 | -6.71% |
| Mar 31, 2024 | -8.03% |
| Dec 31, 2023 | -8.57% |
| Sep 30, 2023 | -15.28% |
| Jun 30, 2023 | -16.18% |
| Mar 31, 2023 | -15.05% |
| Dec 31, 2022 | -26.62% |
| Sep 30, 2022 | -26.59% |
| Jun 30, 2022 | -26.31% |
| Mar 31, 2022 | -25.87% |
| Dec 31, 2021 | -16.48% |
| Sep 30, 2021 | -23.28% |
| Jun 30, 2021 | -23.86% |